晚期肺癌一线免疫化疗后加用局部治疗(NRG-LU002)研究折戟的思考

    Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer

    /

    返回文章
    返回